Leiter, L A, Bain, S C, Hramiak, I, Jódar, E, Madsbad, S, Gondolf, T, Hansen, T, Holst, I & Lingvay, I 2019, ' Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes : A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial ', Cardiovascular Diabetology, vol. 18, 73 . https://doi.org/10.1186/s12933-019-0871-8 Cardiovascular Diabetology Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)